Evelo Biosciences Sees Unusually High Options Volume (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) saw some unusual options trading activity on Wednesday. Investors bought 1,885 put options on the company. This represents an increase of 1,101% compared to the typical daily volume of 157 put options.

Evelo Biosciences Stock Performance

Shares of EVLO stock opened at $0.05 on Thursday. The stock has a market capitalization of $901,550.00, a P/E ratio of 0.00 and a beta of 2.03. The firm’s 50 day moving average is $0.05 and its 200 day moving average is $0.20. Evelo Biosciences has a 12 month low of $0.03 and a 12 month high of $13.93.

Institutional Trading of Evelo Biosciences

A hedge fund recently raised its stake in Evelo Biosciences stock. Vanguard Group Inc. boosted its position in Evelo Biosciences, Inc. (NASDAQ:EVLO) by 129.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 357,711 shares of the company’s stock after purchasing an additional 201,815 shares during the quarter. Vanguard Group Inc. owned about 1.88% of Evelo Biosciences worth $1,402,000 as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 0.31% of the company’s stock.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.